Tom Frew

Fast Tracking of Baoulé Kimberlite Project in Guinea to Trial Mining Stage Stellar Diamonds plc, the London listed (AIM:STEL) diamond development company focused on West Africa, has provided an update on its Baoulé kimberlite diamond project in Guinea. Highlights: · Strategic focus on fast tracking trial mining at the 5ha Baoulé kimberlite pipe · Trial […]

Third Off-take Agreement to Supply Crude Palm Oil from 60 t/hr extraction Mill in Côte d’Ivoire DekelOil Public Limited, operator and 51% owner of an established vertically integrated palm oil project in Côte d’Ivoire, has signed an off-take agreement with Sania Cie, a local refining company in the Côte d’Ivoire, to supply Crude Palm Oil […]

Ferrex plc, an AIM quoted exploration and development company focussed on advancing low capital-intensive iron ore and manganese deposits in Africa through the development cycle and into production, has announced its interim results for the six month ended 31 March 2014. Overview: · Solid progress made in exploring and developing Ferrex’s three core low capex […]

URU Metals, a multi-commodity resource exploration and development company, has nnounced the appointment of John Zorbas as Chief Executive Officer (non-board appointment) with immediate effect. Mr. Zorbas, a resource entrepreneur with a proven track record in the metals exploration and development industry, will provide further expertise to the URU Metals team as it focuses on […]

Company also to resume production at Monaca facility EveryWare Global, Inc. (Nasdaq:EVRY), announced today that it entered into a Forbearance Agreement with the administrative agent and certain other lenders under the Company’s Term Loan Agreement. In addition, EveryWare entered into an amendment to the Company’s asset back loan (“ABL”) agreement with the lenders under...

Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP), a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, announced plans for the clinical development of sapacitabine in a second potential indication for patients with myelodysplastic syndromes (MDS) after treatment failure of...

Alecto Minerals plc (LSE:ALO), an AIM quoted mineral exploration company focussed on West and East Africa, has released its audited final results for the year ended 31 December 2013. Highlights: · Acquisition of the Kossanto Gold Project in western Mali (‘the Kossanto Project’) and associated regional projects, located in a proven gold hosting region · […]

Capital for Colleagues, the ISDX-quoted investment vehicle focused on opportunities in the Employee Owned Business (`EOB’) sector, has announce its unaudited interim results for the period ended 28 February 2014. Highlights: * Specialist investment vehicle focused on securing a leading position in the EOB sector * Makes investments by helping to establish, invest in and […]

AFCR, the AIM listed resources and development company, has announced key board changes which reflect the Company’s evolving strategic development, including fast-tracking its flagship Pickstone-Peerless Gold Project towards production. The following board changes will take effect immediately. Overview: – Appointment of Mr William Battershill as Chairman – a highly...

Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced multiple presentations of clinical data from an ongoing Phase 1 trial of its lead drug candidate, Selinexor (KPT-330), in patients with hematologic malignancies at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL. The data indicate that first-in-class oral...